Effects of SSMC With and Without Myofascial Release in Patients With Sciatica
Trial Parameters
Brief Summary
Sciatica involves a radiating pain along the sciatic nerve, extending from the lower back through the hips and buttocks to each leg. Typically resulting from a herniated disk or spinal stenosis, this condition causes nerve compression that leads to pain, inflammation, and often numbness in the affected leg. Studies have shown that sensorimotor training with myofascial release can be effective in improving pain, lumbar range of motion and functional disability. The aim of this study is to evaluate the effects of Sensorimotor control training with and without myofascial releases on Pain, Lumbar range of motion and functional disability due to sciatica. Participants which meet inclusion criteria will be randomly allocated using online randomization tool into two groups. Group A will receive somatosensory control training with Routine Physical Therapy for 45 minutes with short resting interval for Group B will receive Somatosensory training with myofascial release technique for 45min. Each group will receive treatment sessions of 3 days per week for 12 weeks.
Eligibility Criteria
Inclusion Criteria: * Patient Diagnosed with sciatica (confirmed by clinical examination and imaging) * Patient with Unilateral sciatica pain * Patient Experiencing symptoms for at least 3 months * Pain (VAS) score ≥ 5) in the lumbar and/or lower extremity region in patients. * The disability with a score of at least 20% by the Oswestry Disability Index ( * Stable patient , no recent changes in treatment regimen for sciatica within the past 4 weeks Exclusion Criteria: * Patients with Lumbar spine surgery history within the past 6 months (11) * Patients who have been Another clinical trial participant within the past 3 months (1). * Patients with Physical therapy interventions contraindicated like in Severe cardiovascular disease and Uncontrolled hypertension Acute disc herniation requiring urgent surgical intervention (10). * Patients with Significant comorbidities like malignancy, spinal infection and Severe osteoporosis affecting spine stability (14). * Inability in patients to commu